Purpose. The gastrointestinal tract is home to thousands of commensal bacterial species. Therefore, competition for nutrients is paramount for successful bacterial pathogen invasion of intestinal ecosystems. The human pathogen Vibrio cholerae, the causative agent of the severe diarrhoeal disease, cholera, is able to colonize the small intestine, which is protected by mucus. However, it is unclear which metabolic pathways or nutrients V. cholerae utilizes during intestinal colonization and growth.
INTRODUCTION
Vibrio cholerae is a Gram-negative bacterium that is responsible for causing the pandemic diarrhoeal disease, cholera. The infection usually spreads through the ingestion of contaminated food or water [1, 2] . When inside the body, V. cholerae survives the gastric acid barrier, penetrates the mucus layer, adheres to the intestinal epithelium and produces an array of virulence factors, including cholera toxin (CT) and toxin-coregulated pili (TCP), which causes severe acute diarrhoea [3, 4] .
There are many factors that affect the success of bacterial colonization, but competitive harnessing of limited nutrients is the most important for colonization and survival in the intestinal ecosystem [5, 6] . Since the intestinal microbiome is highly diverse, with thousands of different microbes dwelling inside the organ [7, 8] , specific bacterial colonization requires efficient and preferential consumption of growth-limiting nutrients in comparison to other competitors in this ecosystem [6] [7] [8] . Recently, there have been reports that show the importance of the gut microbiome modulation of V. cholerae infection [9, 10] . However the primary metabolic pathways and nutrients involved in V. cholerae colonization and competition with the gut microbiome are poorly understood.
Of the many important biochemical reactions involved in sustaining life, glycolysis is a key metabolic process that converts glucose into pyruvate during cell respiration. A reverse analogue of glycolysis is gluconeogenesis, which involves converting non-carbohydrate carbon compounds into glucose [11] (Fig. 1a) . During gluconeogenesis, some conversions are irreversible and hence catalyzed by specific enzymes. Examples include the conversion of pyruvate into phosphoenolpyruvate (PEP), which is catalyzed by phosphoenolpyruvate synthase (PpsA) [12] , and the transformation of oxaloacetate into PEP via phosphoenolpyruvate carboxykinase (PckA) [13] . Since these proteins play such important roles in gluconeogenesis, if their genes, ppsA and pckA, are mutated, the organism is expected to experience abnormal cellular functions and altered growth [14] .
In this study, we investigated the relationship between gluconeogenesis and V. cholerae pathogenesis. We found that gluconeogenic substrates are preferred carbon sources for V. cholerae growth in the mouse intestine, especially in a competitive niche. Our data suggest that gluconeogenesis may play a significant role in the pathogenic cycle of V. cholerae.
METHODS
Strains, plasmids and culture conditions All of the strains used in this study were derived from V. cholerae El Tor C6706 [15] . The transposon mutants with insertions in various metabolic pathways were obtained from Dr. John Mekalanos [16] . In-frame deletions of DppsA/pckA mutant were constructed by cloning the flanking regions of the target gene into the suicide vector pWM91 containing a sacB counter-selectable marker [17] . The resulting plasmids were introduced into El Tor C6706 Str r and the double-crossover recombination mutants were selected using sucrose plates and confirmed by PCR. The P tcpA-luxCDABE transcriptional fusion reporter [18] was constructed by cloning tcpA promoter sequences into pBBR-luxCDABE containing a promoterless luxCDABE reporter [19] . The strains were propagated in Luria-Bertani (LB) broth containing appropriate antibiotics at 37 C, unless otherwise noted.
Infant and adult mouse colonization assays
The protocol was approved by the Ethical Committee of Animal Experiments of Nanjing Agricultural University 
. The competitive index (CI) in the small intestine was calculated as the ratio of mutant to WT colonies normalized to the input ratio after 18 h. As a control, WT lacZ À was also co-infected with lacZ + strains. Student's t-test was performed by comparing the CI of the mutant to that of the lacZ À WT. *, P-value <0.05; NS, not significant. Horizontal lines represent the average CI.
[permit number: SYXK (Su) 2017-0007]. All efforts were made to minimize animal suffering. After inoculation, the mice were monitored for signs of distress throughout the duration of the experiments. Moribund animals or those that appeared to be suffering were sacrificed at earlier time points. Upon the termination of the experiments, adult mice were euthanized by carbon dioxide inhalation followed by decapitation. The infant mouse model was used as previously described [20] . Overnight cultures of wild-type (lacZ + ) and individual metabolic mutants (lacZ À ) were mixed in a 1 : 1 ratio and approximately 10 5 V. cholerae cells were intragastrically inoculated into 5-day-old CD-1 suckling mice. The mice were sacrificed after 18 h incubation, and their small intestines were homogenized and plated on LB agar containing 5-bromo-4-chloro-3-indolyl-b-D-galacto-pyranoside (XGal). The ratio of mutants to wild-type colonies was determined. Each experiment consisted of a sample size of three mice.
For the adult mouse model, 5-week-old CD-1 adult mice were separated into two groups and pre-treated with different antibiotics in drinking water [2, 21, 22] . One group of mice was treated with 0.5 % (w/v) vancomycin, 1 % neomycin and 3.75 % aspartame for 72 h. During the final 12 h period, the mice were given 10 % PEG and then fasted. For the other group, the mice were treated with 0.5 % (w/v) streptomycin and 0.5 % aspartame 1 day in advance. Approximately 10 8 wild-type and Dpps/pckA mutant cells were mixed in a 1 : 1 ratio and administered via intragastric gavage to each mouse. Faecal pellets were collected at the indicated time points, resuspended in LB broth, serially diluted and spread on plates containing X-Gal. The competitive index was calculated as the ratio of mutant to wild-type colonies, normalized to the input ratio. Each experiment consisted of a sample size of five mice.
Determination of the strains' in vitro nutrient preferences The strains were grown on LB agar plates overnight and normalized to OD 600 =1.0 in M9 minimal medium without any carbon source. After being washed twice, the cultures were inoculated 1 : 100 into M9 minimal medium [23] supplemented with either reagent-grade glucose (0.5 % w/v), gluconate (0.1 %), glycerol (0.5 %), acetate (0.5 %), aspartate (0.25 %), pyruvate (0.5 %), succinate (0.5 %), N-acetylglucosamine (0.5 %), N-acetylgalactosamine (0.5 %), galactose (0.1 %), sialic acid (0.1 %), fucose (0.5 %), arabinose (0.5 %), maltose (0.1 %), mannose (0.1 %), ribose (0.1 %) or mucin (type II) (Sigma) (0.4 %). To sterilize the mucin, dry powdered mucin was covered with 95 % ethanol and heated at 70 C for 24 h [24] . The cells were incubated at 37 C and the OD 600 was measured at the indicated time points. Three independent experiments were performed.
Determination of bacterial population in mouse intestines
Five-week-old CD-1 mice were separated into three groups and two groups were pre-treated with different antibiotics in drinking water [2, 21, 22] . Faecal samples were collected 24 h after ingestion and bacterial genomic DNA was isolated with the E. Z. N. A. Stool DNA kit (Omega bio-tek). Realtime PCR amplification was carried out using SYBR Premix Ex Taq (TakaRa) and primers targeted to the conserved regions of bacterial 16S rRNA (Unibac-f, CGTGCC AGCCGCGGTAATACG; Unibac-r, GGGTTGCGCTCGTT GCGGGACTTAACCCAACAT) [25, 26] . Standard curves were generated using V. cholerae mid-log-phase cultures with known bacterial numbers [27] . Three independent experiments were performed.
In vitro assays for tcpA expression Overnight cultures of wild-type, DppsA/pckA and DtoxT mutants containing P tcpA-luxCDABE transcriptional fusion plasmids were inoculated 1 : 10 000 into the virulenceinducing AKI medium [28] and incubated without shaking at 37˚C. Luminescence was measured every hour after 3 h and normalized to OD 600 =1.0. Three independent experiments were performed.
Motility assays
The surface movement of V. cholerae was examined on modified LB broth containing 0.25 % (w/v) agar. The plates were air-dried for 1 h, spotted with 1 µl mid-log phase cultures and incubated at 37 C for 6 h. The surface motility zone was then measured. Three independent experiments were performed.
Biofilm assays
The strains were grown overnight and inoculated 1 : 100 into 10Â75 mm borosilicate glass tubes containing 800 µl fresh LB medium and incubated at 28 C without shaking. After 24 h incubation, the content of each tube was removed gently. And the tubes were rinsed with water and stained with 1.2 ml of 1 % crystal violet for 5 min, washed again and dried. Then biofilm was dissolved with 2 ml dimethyl sulfoxide (DMSO) for 2 h and quantified by measuring the OD 570 [29] . Three independent experiments were performed.
RESULTS AND DISCUSSION
Central metabolism influences V. cholerae colonization To investigate the importance of various metabolic pathways in V. cholerae pathogenesis, we first used an infant mouse model [20] to test its colonization. From the defined V. cholerae transposon library [16] , we selected mutants of 10 genes involved in different metabolic pathways such as glycolysis, gluconeogenesis, the citric acid cycle, pentose phosphate pathway, amino acid and nucleotide metabolism (Table 1) . Since metabolic processes often overlap, some of these genes were involved in more than one pathway. As we used lacZ + and lacZ À to distinguish the wild-type and mutants on X-Gal plates, we first reconfirmed that the lacZ À deletion strains colonized equally with the lacZ + wild type in the infant mouse model (Fig. 1b, clear symbols) . We found that the VC0287 mutant colonized as well as the wild-type (Fig. 1b) , suggesting that at least in our assay conditions, the pentose phosphate pathway is not critical in V. cholerae infant mouse colonization. Mutations in VC0736, VC1596, VCA0127 and VCA0945 had small but statistically significant effects on colonization (Fig. 1b, grey symbols) . Mutations in genes associated with fructose/mannose metabolism VC0269 (manA) and VC1827 (manA-2) (green symbols), and that involved in the N-acetylglucosamine catabolic pathway VC1783 (nagA-2) (yellow symbols) showed a 10-to 100-fold reduction in colonization (Fig. 1b) , which is consistent with previous reports [30, 31] . Interestingly, we found that mutations in the key components of gluconeogenesis pathway VC2738 (pckA) and VCA0987 (ppsA) displayed noticeable colonization defects (Fig. 1b, blue  symbols) , indicating the importance of this pathway for V. cholerae growth and maintenance in the intestine. We thus decided to further investigate the role of gluconeogenesis in V. cholerae pathogenesis.
Mutations in the gluconeogenesis pathway lead to a V. cholerae growth defect in gluconeogenic substrates and mucin Gluconeogenesis is well conserved between bacteria and humans. Two of the many components involved in gluconeogenesis are PckA, a phosphoenolpyruvate (PEP) carboxykinase that catalyzes the conversion of oxaloacetate to PEP [13] , and PpsA, a PEP synthase that converts pyruvate to PEP [12] (Fig. 1a) . To determine the effect of gluconeogenesis on V. cholerae physiology and pathogenesis, we constructed a DppsA/pckA double in-frame deletion mutant, which is predicted to have the gluconeogenesis pathway completely disrupted. As PpsA and PckA catalyze complementary reactions, deleting the ppsA and pckA genes would shut down the conversion of the TCA cycle metabolites to PEP entirely. First, we tested the ability of the mutant to utilize gluconeogenic substrates. We found that the wild-type could utilize both glycolytic (such as glucose, gluconate and glycerol) and gluconeogenic substrates downstream of PEP (acetate, aspartate, pyruvate and succinate) for growth ( Table 2 ). On the other hand, the DppsA/pckA mutant could grow well on glycolytic substrates but failed to grow on gluconeogenic substrates (Table 2 ). These growth patterns are similar to those reported for Escherichia coli [32, 33] , suggesting that the gluconeogenesis pathway is conserved between these two bacteria.
To better understand the colonization defect of the gluconeogenesis mutant, we compared the growth of the DppsA/pckA mutant to that of the wild-type under virulence-inducing conditions [34] . We found that the mutant grew well under this condition (Fig. 2a) . We also measured the expression of tcpA, a major virulence determinant, using a luminescence reporter system and found no detectable difference between the wild-type and the DppsA/pckA mutant under this condition (Fig. 2b) . These results imply that the colonization defect of gluconeogenesis mutant may not be due to disruptions in virulence factor production, but might rather be from the important role gluconeogenesis plays in vivo.
The small intestine is thoroughly protected by mucus, a structurally complex layer that functions as a barrier to toxic xenobiotics, bacteria and viruses. However, since V. cholerae is capable of colonizing the small intestine despite such a defence system, we decided to investigate whether gluconeogenesis plays a role in the growth of V. cholerae in mucus.
Mucins are the major component of mucus. They are a family of proteins that are extensively glycosylated by O-linked oligosaccharides and serve as important carbon sources for microbial growth [35, 36] . We grew V. cholerae in M9 minimal medium supplemented with mucin as the sole carbon source, without shaking. Since stationary incubation establishes partially anaerobic conditions, we chose to model the limited oxygen availability of mucosal tissues in the mouse intestine closely [34, 37] . Viable cells were enumerated every 12 h. When cultured alone, the wild-type was able to utilize mucin as a sole carbon source and grew to maximum density within 12 h (Fig. 3a) . Single-inoculated DppsA/pckA mutant cells also reached maximal growth within 12 h, but the bacterial number remained approximately 10-fold lower than that of the wild-type, suggesting that gluconeogenesis is important for V. cholerae utilization of mucin. Interestingly, when the DppsA/pckA mutant was co-cultured with the wild-type, the cell density reached its highest level in the first 12 h and then decreased sharply over time (Fig. 3b) . At the 48 h time point, the difference in the number of viable cells between the wild-type and the DppsA/pckA mutant was over 1000-fold. To test whether wild-type might produce unknown metabolites that have bactericidal activity towards the DppsA/pckA mutant, we collected the supernatant from the wild-type that had grown to maximum cell density in mucin broth and added it to the single-inoculated DppsA/pckA M9-mucin cultures. We found that adding this supernatant did not impact on DppsA/pckA growth (data not shown). Further studies are required to understand the exact mechanism of the mucin-promoted death of the gluconeogenic mutants via their parental strains.
To date, at least 13 sugars have been identified in cecal mucus [7, 38, 39] , and 5 major mucin sugars are known to be L-fucose, D-galactose, sialic acids, N-acetylgalactosamine and N-acetylglucosamine [39] . To further investigate whether V. cholerae preferentially uses certain sugars in mucin for gluconeogenesis, we tested its growth in nine mucus sugars ( Table 2 ) and found that N-acetylgalactosamine, D-galactose, L-fucose and arabinose cannot be metabolized by V. cholerae. The other five sugars offered varying support for V. cholerae growth, and the deletion of the ppsA and pckA genes did not seem to have any impact. This suggested that the gluconeogenesis pathway of V. cholerae may preferentially use different components of mucin than the ones we tested here.
Gluconeogenesis is critical for V. cholerae maintenance in vivo Bacteria in the gut can coexist with other microflora if they are capable of utilizing certain limited nutrients more efficiently than others [8, 40] . The metabolic pathways or nutrients necessary for growth may differ for each colonizer, and recent studies have suggested that some pathogens use glycolytic nutrients, while others may use gluconeogenic nutrients or both to adapt to diverse host habitats [41] [42] [43] [44] .
To investigate the effects of gut microbiome on V. cholerae gluconeogenesis, we applied two adult mice models. Adult mice were selected over infant mice for their well-developed intestinal mucus layers. The standard protocol for V. cholerae colonization in adult mice requires the partial eradication of commensal flora with streptomycin [21, 45] , but pre-treatment with additional antibiotic cocktails has also shown effective colonization through further elimination of intestinal commensals [22] . To confirm the effects of the two antibiotic treatments on the gut microbiota, we performed real-time PCR to determine the bacterial loads in both colonization models. Fig. 4(a) shows that after 24 h streptomycin treatment (blue bar) removed approximately 90 % of the commensal flora and additional antibiotics reduced the bacterial load in the gut significantly further (orange bar). We infected the wild-type and the DppsA/ pckA mutant at a 1 : 1 ratio and collected faecal pellets every day for 5 days to determine the output ratio of the mutant to the wild-type. As shown in Fig. 4(b) , in streptomycintreated mice, the DppsA/pckA mutant was continuously outcompeted by the wild-type (blue symbols). At day 5 post-inoculation, the competitive index dropped to 0.0016. In the antibiotic cocktail-treated mice, the DppsA/pckA mutant also colonized poorly in relation to the wild-type (10-100-fold difference) (orange symbols), but the defect was significantly less prominent compared to that present in streptomycin-treated mice. These results suggest that in the presence of other gut microbiota, gluconeogenesis in biosynthesis is critical for V. cholerae survival in vivo, meaning that the DppsA/pckA mutant is at a significant disadvantage when growing in such a competitive environment. However, further removal of the gut commensals allows the DppsA/pckA mutant to acquire carbon sources other than gluconeogenic substrates for growth. We showed that the DppsA/pckA mutants were defective in gluconeogenic substrates such as acetate and succinate (Table 2 ). These metabolites are often rich in the gut as metabolic products from members of the microbiota. For example, enteric pathogens such as Salmonella Typhimurium and Citrobacter rodentium utilize the microbiota-derived fermentation product succinate to promote intestinal colonization [46, 47] . Further experiments will be performed to test whether V. cholerae can use gluconeogenesis and benefit from gut microbiota metabolites such as succinate.
In addition, the role of gluconeogenesis in V. cholerae colonization can be compared to that in E. coli. Previous studies have reported that most strains of E. coli predominantly utilize glycolytic substrates for colonization and growth in the mouse intestine, although some pathogenic strains can strategically switch to utilizing gluconeogenic substrates to maintain survival when large numbers of commensal E. coli are present [33] . Our data indicate that, unlike E. coli, and DppsA/pckA (lacZ À ) strains were grown on LB agar plates overnight and normalized to OD 600 =1.0 in M9 minimal medium without any carbon source. After being washed twice, the cultures were inoculated 1 : 100 into M9 supplemented with sterilized mucin separately (a) or together (b). The cells were sampled every 12 h and plated on LB agar containing X-Gal for c.f.u. ml À1 determination.
V. cholerae relies on gluconeogenesis for colonization and growth, especially in competitive niches.
Gluconeogenesis is involved in V. cholerae motility and biofilm formation We also examined whether gluconeogenesis has other physiological functions that are important for V. cholerae pathogenesis. We examined V. cholerae swimming motility on semi-solid LB agar plates and found that the DppsA/ pckA mutant was defective in motility (Fig. 5a ). Given that the growth rate of DppsA/pckA mutant was indistinguishable from that of the wild-type in LB medium, these data suggest that gluconeogenesis in V. cholerae impacts on its swimming behaviour. Since V. cholerae must penetrate the mucosal layers of the host small intestine to colonize the epithelial surface during infection, it may sense mucin as a Fig. 4 . Effects of gluconeogenesis on V. cholerae colonization of adult mouse small intestines. (a) Gut flora quantification. Total DNA was purified from stool samples collected from mice treated or untreated with different sets of antibiotics for 24 h and then subjected to real-time PCR using primers targeted to the conserved regions of bacterial 16S rRNA. The results were normalized against the standard curve generated using V. cholerae mid-log phase cultures with known bacterial numbers. The data consist of the means and standard deviations from nine independent experiments. *, P<0.05 (Student's t-test). (b) Adult mouse competition assays. Five-weekold CD-1 adult mice were separated in two groups and pre-treated with different antibiotics in drinking water. For one group of mice, an antibiotic cocktail was applied 72 h beforehand, while the other was only treated with streptomycin. Then 10 8 cells consisting of a 1 : 1 mixture of the wild-type (WT) and the Dpps/pckA mutant were gavaged into adult mice. Faecal pellets were collected every day and the output ratio of the mutant to the wild-type was determined by plating on LB agar plates containing X-Gal. Horizontal lines represent the competitive index. *, P<0.05 (Student's t-test).
host signal to modulate its transcriptional programming [24, 48] . Thus, the gluconeogenesis pathway may contribute further to V. cholerae pathogenesis by also regulating its motility.
Another factor that is crucial for the environmental survival and pathogenesis of V. cholerae is the successful formation of biofilm [49] [50] [51] . In order to examine whether gluconeogenesis affects this process, we performed biofilm formation assays [51] and found that the DppsA/pckA mutant formed significantly fewer biofilms than the wildtype (Fig. 5b) . As both the mutant and the wild-type grew at similar rates in rich medium (data not shown), our results suggests that the gluconeogenesis pathway may also be involved in pathogenesis through the regulation of biofilm formation.
The mammalian gastrointestinal tract is home to a community of trillions of micro-organisms, with a wide variety of nutrients. In such a competitive environment, being able to strategically utilize different carbon sources or have priority access to certain nutrients over others is necessary for better colonization. In this study, we showed that V. cholerae strains can utilize both glycolytic and gluconeogenic substrates for growth. Unlike for E. coli, gluconeogenic substrates are the priority carbon sources for V. cholerae growth in the mouse intestine, especially in the competitive niche. The defect in the gluconeogenesis pathway does not influence its virulence, but does decrease its motility and disrupt its biofilm formation. Taken together, we show that there is a significant role for gluconeogenesis during the pathogenic cycle of V. cholerae.
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